Board Of Directors

Mr Charles Wang Chong Guang
Non-Executive Chairman

Mr Wang has extensive experience in corporate finance, mergers and acquisitions, and financial management, with over 20 years in the healthcare industry across both listed and private companies.

He is currently the Group Chief Executive Officer of Luye Medical Group. He joined the Group as Chief Financial Officer in February 2015 and was appointed Group Chief Executive Officer in April 2017. Prior to this, he also served as Group Vice President of Luye Pharma, where he oversaw mergers and acquisitions and capital market activities.

Mr Wang began his career with Kingston Smith Chartered Accountants in London before joining Coopers & Lybrand in Hong Kong. He subsequently held senior finance roles across various healthcare and pharmaceutical companies, including Asia Renal Care Limited, Tongjitang Chinese Medicine Limited, Trauson Holdings Company Limited, and China NT Pharma Group Company Limited.

Mr Wang holds a Bachelor's Degree in Economics (Honours) from the University of Leeds and is a member of the Institute of Chartered Accountants of England and Wales.

Ms Aona Liu
Non-Executive Director

Ms Liu has experience in strategic consulting, mergers and acquisitions, and healthcare management across Singapore, Japan, Australia, and China.

She is currently the Executive Chairperson of Luye Medical Group, the healthcare services platform of Luye Life Sciences Group Ltd, which focuses on specialties including cosmetic surgery, mental health, and rehabilitation.

Ms Liu holds a Bachelor of Arts (Honours) and a Master of Arts (Honours) in Economics from the University of Edinburgh, and a Master of Science in International Healthcare Management from Imperial College London.

Ms Alice Ng Bee Yee
Independent Director

Ms Ng has over 20 years of experience in corporate finance, including initial public offerings, reverse takeovers, and financial advisory, as well as continuing sponsorship of Catalist-listed companies.

She is currently the Head of Finance at Golden Energy and Resources Pte. Ltd. Prior to this, she was Director of Continuing Sponsorship at ZICO Capital Pte. Ltd., where she advised Catalist-listed companies on compliance with SGX-Catalist Rules.

Ms Ng has also held senior corporate finance roles at Canaccord Genuity Singapore Pte. Ltd., CIMB Bank Berhad, Phillip Securities Pte. Ltd., and Hong Leong Finance Limited. She began her career in audit and compliance.

Ms Ng holds a Bachelor of Accountancy from Nanyang Technological University.

Mr Chua Keng Woon
Independent Director

Mr Chua has over 16 years of experience in banking and finance, with a focus on corporate advisory and capital raising activities. He was previously with Canaccord Genuity Singapore Pte. Ltd., where he last held the position of Senior Director, Equity Capital Markets.

Mr Chua holds a Bachelor of Business (Financial Analysis) from Nanyang Technological University and is a Chartered Financial Analyst.

He was appointed as an Independent Director of AsiaMedic Limited on 15 August 2018. He serves as Chairman of the Nominating Committee and a member of the Audit and Risk Management Committee.

He is currently the Lead Independent Director of Soon Lian Holdings Limited.

Mr Leong Yew Meng
Independent Director

Mr Leong brings over 30 years of experience in the healthcare industry.

He began his career at Singapore General Hospital and subsequently served as Chief Operating Officer of the National University Hospital. He later joined Thomson Medical Group as Group Chief Executive Officer.

Mr Leong also served as Chief Executive Officer of Woodbridge Hospital/Institute of Mental Health and concurrently as Chief Executive Officer of National Healthcare Group Polyclinics.

He has held regional leadership roles, including Chief Executive Officer (Greater China) at Parkway Pantai Ltd, where he oversaw operations and expansion across China and Hong Kong. He subsequently served as Chief Executive Officer of Shanghai Fosun Hospital Investment (Group) Co. Ltd., leading hospital operations and development projects.

Mr Leong has also served as a board member of United Family Health, a leading private healthcare provider in China.